401(k) · DOL Form 5500 · 2023

Ipsen Biopharmaceuticals, Inc 401(k) Plan

Data updated 2026-08-11

$166M
Total assets: 622
Participants: 94th
Percentile by assets: $266,693
Avg per participant

Official DOL plan name: Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan · Sponsored by Ipsen Biopharmaceuticals, Inc · New Jersey · Wholesale Trade

$166M in assets, 622 participants

Ipsen Biopharmaceuticals, Inc's Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan reported $166M in total assets and 622 participants in its 2023 DOL Form 5500 filing, ranking in the 94th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

94th percentile by assets (of 127,072 plans)
#6,017 in Wholesale Trade (6,309 peers)

Where Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan sits by assets

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan sits in the top 10% of all filed plans by assets, $166M for 622 participants (~$266,693/participant), up 32.7% in 2023.

$166M
total plan assets (2023 EOY): 622
covered participants: 94th
percentile by assets (of 127,072 plans): $266,693
avg assets per participant

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan reported net income rose from -$10M in the plan year 2022 filing to $41M in the plan year 2023 filing.
Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan end-of-year assets rose from $125M in the plan year 2022 filing to $166M in the plan year 2023 filing.
Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan reported participants rose from 505 in the plan year 2022 filing to 622 in the plan year 2023 filing.

See the national 2022→2023 release diff →

State

New Jersey

Industry

Wholesale Trade

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan vs the 2023 asset distribution

By assets, Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan outranks 94% of the 127,072 plans that filed a Form 5500 for the 2023 plan year, and holds roughly 1.7x the national average plan size of $100M (721 average participants).

Scale-class filing particulars (2023)

Total Assets (Beginning of Year)	$125M
Net Assets (End of Year)	$166M
Net Income	$41M
Employer EIN	260042539
Plan Effective Date	2005-01-01
Filing Status	FILING RECEIVED

Sponsor Plan History (Ipsen Biopharmaceuticals, Inc)

Total plan assets by year, all Ipsen Biopharmaceuticals, Inc plans on file

Year	Plans	Participants	Total Assets
2022	1	505	$125M
2023	1	622	$166M
2024	1	692	$206M

Nearby 401(k) Plans in New Jersey

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan vs. nearby 401(k) plans in New Jersey, assets vs. participants

JPMorgan Chase 401(k) Savings Plan $44.6B · 176,610
Verizon Savings Plan for Management Employees $27.8B · 78,072
Johnson and Johnson Savings Plan $22.2B · 41,291
Ernst & Young Retirement Savings Plan $15.5B · 59,346
Merck US Savings Plan $13.4B · 26,850

Compare Ipsen Biopharmaceuticals, Inc. U.S. 401(… side-by-side with 3 peers →

Similar-Sized 401(k) Plans Nationally

401(k) plans in other states closest to Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan by total assets, not by location.

Moelis & Company Group LP 401(k) Profit Sharing Plan (NY) $166M · 806
Cmt Profit Sharing/401(k) Plan (IL) $166M · 406
Fj Management Inc. 401(k) Plan (UT) $166M · 4,632
Homestreet, Inc 401(k) Savings Plan (WA) $166M · 955

Frequently Asked Questions

How did Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan assets move in 2023? ▼

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan surged - up 32.7% during 2023, from $125M to $166M. Reported net income was $41M.

How have Ipsen Biopharmaceuticals, Inc plan assets changed over time? ▼

Across 3 plan years on file (2022-2024), Ipsen Biopharmaceuticals, Inc's sponsor-wide assets grew 64.6%, from $125M to $206M.

Where does Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan rank by assets among Form 5500 filers? ▼

Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan ranks in the 94th percentile by end-of-year assets among 127,072 plans that reported assets for plan year 2023 (in the top 10% of all filed plans by assets).

Which 401(k) plans are similar in size to Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan? ▼

Among 401(k) plans in other states, the closest by assets is Moelis & Company Group LP 401(k) Profit Sharing Plan in NY ($166M, 806 participants).

Next read for Ipsen Biopharmaceuticals, Inc. U.S. 401(…

Scale reading

Ways to act on Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan's numbers.

By total assets, Ipsen Biopharmaceuticals, Inc. U.S. 401(k) Plan ranks in the top 10% of all filed plans by assets. See the largest plans
Compare it side-by-side against 3 similar 401(k) plans in New Jersey. Compare plans
Ipsen Biopharmaceuticals, Inc's sponsor-wide assets have grown 64.6% since 2022 across 3 plan years on file. More Wholesale Trade plans

Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2023.

Source: DOL EFAST2 filing system (efast.dol.gov) - original filing retrieval by EIN 260042539.